Europe Dermatology Imaging Devices Market Size, Share & Trends Analysis Report By End-use (Hospitals, Dermatology Centers, and Specialty Clinics), By Modality, By Application, By Country and Growth Forecast, 2023 - 2030

Europe Dermatology Imaging Devices Market Size, Share & Trends Analysis Report By End-use (Hospitals, Dermatology Centers, and Specialty Clinics), By Modality, By Application, By Country and Growth Forecast, 2023 - 2030

The Europe Dermatology Imaging Devices Market would witness market growth of 12.1% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Dermatology Imaging Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $349.4 million by 2030. The UK market is registering a CAGR of 11.1% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 12.9% during (2023 - 2030).

It supports the growing field of tele dermatology, where healthcare professionals remotely diagnose and monitor skin conditions. These devices enable patients to capture high-quality images of their skin, which can then be transmitted to dermatologists for analysis. This approach enhances accessibility to dermatological care, especially for individuals in remote or underserved areas. It plays a vital role in research and education. They allow for the documentation of skin conditions for research purposes, facilitating the study of disease progression and treatment outcomes. Additionally, these devices are valuable tools for educational purposes, enabling students and trainees to learn about dermatological conditions through detailed visualizations.

Optical coherence tomography (OCT) provides detailed cross-sectional images of subsurface skin structures. This capability is particularly useful in assessing conditions like basal cell carcinoma and understanding skin lesions' depth and extent. Visualizing subsurface structures without the need for invasive procedures enhances diagnostic precision. Dermatology imaging devices aid in tracking changes in the characteristics of skin lesions over time. This longitudinal monitoring is crucial for assessing the stability or progression of potentially concerning lesions. The ability to compare images taken at different intervals contributes to a comprehensive understanding of the evolution of skin conditions.

Similarly, the Global Cancer Observatory estimated that in France in 2022, there were about 483,568 new cases of cancer, of which 15,729 were melanoma cases. There are 61,520 cases of melanoma over the five years. Thus, all these factors will uplift the regional market’s expansion in the coming years.

Based on End-use, the market is segmented into Hospitals, Dermatology Centers, and Specialty Clinics. Based on Modality, the market is segmented into Dermatoscope, Digital Photographic Imaging, Optical Coherence Tomography (OCT), High Frequency Ultrasound, and Others. Based on Application, the market is segmented into Skin Cancers, Inflammatory Dermatoses, Plastic & Reconstructive Surgery, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Canfield Scientific, Inc.
• FotoFinder Systems GmbH
• Courage + Khazaka electronic GmbH
• FUJIFILM VisualSonics, Inc. (Fujifilm Holdings Corporation)
• Longport, Inc.
• Michelson Diagnostics Ltd
• DRAMINSKI S. A.
• Cortex Technology ApS

Europe Dermatology Imaging Devices Market Report Segmentation

By End-use

• Hospitals
• Dermatology Centers
• Specialty Clinics

By Modality

• Dermatoscope
• Digital Photographic Imaging
• Optical Coherence Tomography (OCT)
• High Frequency Ultrasound
• Others

By Application

• Skin Cancers
• Inflammatory Dermatoses
• Plastic & Reconstructive Surgery
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe